EUVIMEDEUVIMED entdecken
Crossref

The efficacy of tranexamic acid in prevention and treatment of post-inflammatory hyperpigmentation: A pilot study

Mavra Masood iD, Brittany Lane, Jalal Maghfour, Marissa Ceresnie iD, Mohsen Mokhtari, Redina Bardhi, Indermeet Kohli, David Ozog, Tasneem F Mohammad

Clinical and Experimental Dermatology · 2026

DOI: 10.1093/ced/llag082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2026. Verfasst von Mavra Masood und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, VCU Health System, Richmond, VA, USA. Hauptthemen laut MEDLINE: Tranexamic Acid, Hyperpigmentation, Antifibrinolytic Agents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-inflammatory hyperpigmentation (PIH) is a common complication following trauma or cutaneous inflammation, particularly affecting individuals with skin of color. Tranexamic acid (TXA) is a lysine analogue with antifibrinolytic properties and has been used as an off-label agent for melasma and procedural PIH. This pilot study evaluated the efficacy of oral TXA in the prevention and treatment of PIH using a validated in-vivo model. A baseline site was treated with 30% trichloroacetic acid (TCA) to induce PIH (control). After PIH developed, another site was induced and patients started oral TXA 650mg for 4 weeks. Both sites were assessed for pigmentation changes at day 56 using standardized photography, Investigator Global Assessment (IGA), colorimetry, and digital reflectance spectroscopy. While trends toward reduced pigmentation were observed in the TXA-prevention group, none reached statistical significance. Oral TXA may play a role in preventing PIH, but did not significantly reduce pigmentation in established PIH lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidHyperpigmentationAntifibrinolytic AgentsHumansPilot ProjectsFemaleMaleAdultAdministration, OralTreatment OutcomeMiddle AgedTrichloroacetic Acid

Substanzen

Tranexamic AcidAntifibrinolytic AgentsTrichloroacetic Acid

Autor:innen und Institutionen

  • Department of Dermatology, VCU Health System, Richmond, VA, USA.
  • Department of Internal Medicine, Henry Ford Jackson Hospital, Jackson, MI, USA.
  • Department of Dermatology, Henry Ford Health, Detroit, MI, USA.
  • Department of Dermatology, Lake Granbury Medical Center, Dallas, TX, USA.
  • Oakland University William Beaumont School of Medicine, Auburn Hills, MI, USA.
  • Reveal Research Institute, Dallas, TX, USA.

ORCID-Profile: Mavra Masood, Marissa Ceresnie

Zitieren

APA

Masood, M., Lane, B., Maghfour, J., Ceresnie, M., Mokhtari, M., Bardhi, R., Kohli, I., Ozog, D., & Mohammad, T. F. (2026). The efficacy of tranexamic acid in prevention and treatment of post-inflammatory hyperpigmentation: A pilot study. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag082

Vancouver

Masood M, Lane B, Maghfour J, Ceresnie M, Mokhtari M, Bardhi R, et al. The efficacy of tranexamic acid in prevention and treatment of post-inflammatory hyperpigmentation: A pilot study. Clinical and Experimental Dermatology. 2026. doi:10.1093/ced/llag082

BibTeX
@article{Masood2026,
  author = {Masood, Mavra and Lane, Brittany and Maghfour, Jalal and Ceresnie, Marissa and Mokhtari, Mohsen and Bardhi, Redina and Kohli, Indermeet and Ozog, David and Mohammad, Tasneem F},
  title = {The efficacy of tranexamic acid in prevention and treatment of post-inflammatory hyperpigmentation: A pilot study},
  journal = {Clinical and Experimental Dermatology},
  year = {2026},
  doi = {10.1093/ced/llag082}
}
Kostenlos starten →